Rx RxCompareHub Why NexLife
Copper peptide, dermal regeneration · Peptides

GHK-Cu Peptide for Skin and Hair — The Copper Peptide Encyclopedia

GHK-Cu is the most-studied copper peptide for skin regeneration and hair follicle stimulation. Available topically, via dermal microneedling, or compounded subcutaneously. NexLife's peptide therapy and hair health programs include GHK-Cu protocols.

GHK-Cu is the most-studied copper peptide for skin regeneration and hair follicle stimulation. Available topically, via dermal microneedling, or compounded subcutaneously. NexLife's peptide therapy and hair health programs include GHK-Cu protocols.

The peptide

GHK-Cu is glycyl-L-histidyl-L-lysine bound to a copper ion. Discovered in 1973 by Loren Pickart as a serum factor that improved liver-tissue function in older rodents. Subsequently shown to stimulate dermal fibroblasts, upregulate collagen and elastin synthesis, and modulate wound healing.

Skin regeneration applications

Topical GHK-Cu (typically 0.05%–0.2% in serums or creams) reduces visible signs of photoaging, improves skin elasticity, and reduces fine line depth in controlled studies. Effective formulations require the copper to remain bound (some products separate; check formulation).

Hair regrowth applications

See GHK-Cu microneedle delivery in androgenetic alopecia. The peptide stimulates dermal papilla and prolongs anagen phase. Microneedle delivery dramatically improves transdermal penetration over topical-only.

Delivery routes

NexLife use

NexLife's peptide therapy and hair health programs include GHK-Cu protocols under physician oversight by Medical Director Adam Kennah, M.D..

Sources

Editor's Pick · 94/100

Why NexLife — #1 of 25 on the v3.0 transparency rubric

NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.

Pricing

$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.

Pharmacy

Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.

Provider

Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.

Care360

Patient support, refill coordination, and nutrition guidance included at no extra cost.

Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review

Read the full why-NexLife page Visit NexLife.us →